Literature DB >> 12045112

RNA editing by adenosine deaminases that act on RNA.

Brenda L Bass1.   

Abstract

ADARs are RNA editing enzymes that target double-stranded regions of nuclear-encoded RNA and viral RNA. These enzymes are particularly abundant in the nervous system, where they diversify the information encoded in the genome, for example, by altering codons in mRNAs. The functions of ADARs in known substrates suggest that the enzymes serve to fine-tune and optimize many biological pathways, in ways that we are only starting to imagine. ADARs are also interesting in regard to the remarkable double-stranded structures of their substrates and how enzyme specificity is achieved with little regard to sequence. This review summarizes ongoing investigations of the enzyme family and their substrates, focusing on biological function as well as biochemical mechanism.

Mesh:

Substances:

Year:  2001        PMID: 12045112      PMCID: PMC1823043          DOI: 10.1146/annurev.biochem.71.110601.135501

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  120 in total

1.  RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.

Authors:  C M Niswender; K Herrick-Davis; G E Dilley; H Y Meltzer; J C Overholser; C A Stockmeier; R B Emeson; E Sanders-Bush
Journal:  Neuropsychopharmacology       Date:  2001-05       Impact factor: 7.853

Review 2.  Functions and mechanisms of RNA editing.

Authors:  J M Gott; R B Emeson
Journal:  Annu Rev Genet       Date:  2000       Impact factor: 16.830

Review 3.  RNA editing by base deamination: more enzymes, more targets, new mysteries.

Authors:  A P Gerber; W Keller
Journal:  Trends Biochem Sci       Date:  2001-06       Impact factor: 13.807

4.  Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site.

Authors:  O M Stephens; H Y Yi-Brunozzi; P A Beal
Journal:  Biochemistry       Date:  2000-10-10       Impact factor: 3.162

5.  Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis.

Authors:  Q Wang; J Khillan; P Gadue; K Nishikura
Journal:  Science       Date:  2000-12-01       Impact factor: 47.728

6.  Ca2+ permeability of unedited and edited versions of the kainate selective glutamate receptor GluR6.

Authors:  J Egebjerg; S F Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

7.  Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.

Authors:  K A Lehmann; B L Bass
Journal:  Biochemistry       Date:  2000-10-24       Impact factor: 3.162

8.  The role of RNA editing of kainate receptors in synaptic plasticity and seizures.

Authors:  B Vissel; G A Royle; B R Christie; H H Schiffer; A Ghetti; T Tritto; I Perez-Otano; R A Radcliffe; J Seamans; T Sejnowski; J M Wehner; A C Collins; S O'Gorman; S F Heinemann
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

9.  A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity.

Authors:  M J Palladino; L P Keegan; M A O'Connell; R A Reenan
Journal:  Cell       Date:  2000-08-18       Impact factor: 41.582

10.  The mechanism of adenosine to inosine conversion by the double-stranded RNA unwinding/modifying activity: a high-performance liquid chromatography-mass spectrometry analysis.

Authors:  A G Polson; P F Crain; S C Pomerantz; J A McCloskey; B L Bass
Journal:  Biochemistry       Date:  1991-12-10       Impact factor: 3.162

View more
  545 in total

1.  Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2.

Authors:  Cyril X George; Charles E Samuel
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Age-related gene-specific changes of A-to-I mRNA editing in the human brain.

Authors:  A Nicholas; J P de Magalhaes; Y Kraytsberg; E K Richfield; E Y Levanon; K Khrapko
Journal:  Mech Ageing Dev       Date:  2010-06-09       Impact factor: 5.432

3.  Serotonin 2c receptor RNA editing in major depression and suicide.

Authors:  Rebecca Lyddon; Andrew J Dwork; Mehdi Keddache; Larry J Siever; Stella Dracheva
Journal:  World J Biol Psychiatry       Date:  2012-03-09       Impact factor: 4.132

4.  Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants.

Authors:  Leath A Tonkin; Brenda L Bass
Journal:  Science       Date:  2003-12-05       Impact factor: 47.728

5.  Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains.

Authors:  Nandadeva Lokugamage; Alexander N Freiberg; John C Morrill; Tetsuro Ikegami
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

6.  Enzymatic interconversion of isomorphic fluorescent nucleosides: adenosine deaminase transforms an adenosine analogue into an inosine analogue.

Authors:  Renatus W Sinkeldam; Lisa S McCoy; Dongwon Shin; Yitzhak Tor
Journal:  Angew Chem Int Ed Engl       Date:  2013-11-29       Impact factor: 15.336

Review 7.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

8.  Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation.

Authors:  Sadeem Ahmad; Xin Mu; Fei Yang; Emily Greenwald; Ji Woo Park; Etai Jacob; Cheng-Zhong Zhang; Sun Hur
Journal:  Cell       Date:  2018-01-25       Impact factor: 41.582

9.  Transcriptome profiling of the cancer and normal tissues from gastric cancer patients by deep sequencing.

Authors:  Fei-Gong Zhang; Zhi-Ying He; Qiang Wang
Journal:  Tumour Biol       Date:  2014-04-30

10.  Analysis of human mRNAs with the reference genome sequence reveals potential errors, polymorphisms, and RNA editing.

Authors:  Terrence S Furey; Mark Diekhans; Yontao Lu; Tina A Graves; Lachlan Oddy; Jennifer Randall-Maher; LaDeana W Hillier; Richard K Wilson; David Haussler
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.